Alasdair Coles, MD, University of Cambridge, shares his thoughts on the efficacy of alemtuzumab for patients with multiple sclerosis (MS) at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.
Mikkel Anthonisan, MD, highlights his experience as the founder of Oceans of Hope, a global voyage to change the perception of multiple sclerosis, at the 2014 Joint ACTRIMS-ECTRIMS Meeting.
For patients with diabetes mellitus undergoing degenerative lumbar spine surgery, suboptimal glycemic control contributes to increased risk of complications and poor outcomes, according to a study published in the Sept. 15 issue of Spine.
When autoimmune diseases like multiple sclerosis attack a patient’s body from the inside it can be a difficult reminder of how hard it can be to treat a condition from the inside out.
Many guidelines recommend the use of acetaminophen (called paracetamol in Europe) and/or NSAIDs for the treatment of acute low back pain. The reason for this is acetaminophen and NSAIDs are relatively safe and effective with regard to managing musculoskeletal pain. This study determined the efficacy of acetaminophen alone vs. placebo for acute low back pain.
While opioids represent an important tool in treating pain, it would be foolish to not acknowledge that opioids and opioid prescribing are fraught with potential hazards. However, through the development of a strong risk mitigation platform, primary care physicians can minimize the risks to their patients, as well as to their own practices.